Describes the analytical evaluation of a new point-of-care HbA1c analyzer for office-based use.
May support office-based HbA1c testing; leaves open clinical validation and outcome studies.
Hemoglobin A1c (HbA1c) measurements are important for monitoring glycemic control in patients with diabetes. The positive impact of point-of-care HbA1c measurements on patient management is described in the literature. The general analytical requirements for HbA1c testing are described. The analytical evaluation of a new point-of-care HbA1c analyzer, suitable for a physician's office, against these requirements is described.
No takes yet. Share an insight, caveat, or question.
Trefor Higgins (2007) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: